Alkermes plc.

ALKS chart

Alkermes plc. news

• Narcolepsy Pipeline Outlook 2026: Oral, Injectable, and Novel Delivery Candidates Advancing Through Clinical Trials | Novartis, Shionogi Inc., Takeda, Avadel Pharma, Harmony Biosciences, Jazz Pharma

  StreetInsider · Oct 27, 9:56 AM EDT

• Earnings Preview: Tarsus Pharmaceuticals, Inc. (TARS) Q3 Earnings Expected to Decline

  Yahoo Finance · Oct 27, 9:00 AM EDT

• In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

  Law360 · Oct 26, 7:21 PM EDT

• 3 Stocks That Could Benefit If Tax Haven Fears Fade

  Simply Wall Street · Oct 26, 6:50 PM EDT

• Alkermes plc Estimates – NASDAQ:ALKS

  TradingView · Oct 23, 10:30 AM EDT

• Alkermes (ALKS) Sleep Research Push Keeps Undervalued Narrative In Focus

  Simply Wall Street · Oct 22, 2:48 PM EDT

• Supreme Court Patent Cases

  Patently-O · Oct 21, 2:47 PM EDT

• ALKS Q3'26 Earnings: revenue estimate is 463.60M USD

  TradingView · Oct 21, 7:00 AM EDT

• Alkermes to Report Third Quarter Financial Results on November 3, 2026

  Yahoo Finance · Oct 20, 4:00 PM EDT

• Earnings Preview: Alkermes (ALKS) Q3 Earnings Expected to Decline

  Yahoo Finance · Oct 20, 9:00 AM EDT

• Workday downgraded, Fox Corp. upgraded: Wall Street's top analyst calls

  Yahoo Finance · Oct 16, 9:38 AM EDT

• HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?

  Yahoo Finance · Oct 16, 7:12 AM EDT

Alkermes plc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-21
• 8-KFORM 8-K2026-09-16
• 8-K8-K2026-08-12
• 8-K/A8-K/A2026-08-03
• 10-Q10-Q2026-07-28
• 8-K8-K2026-07-28
• 8-K8-K2026-07-08
• 8-K8-K2026-06-15
• 8-K8-K2026-05-20
• 8-K8-K2026-05-12
• 10-Q10-Q2026-05-05
• 8-K8-K2026-05-05

About Alkermes plc.

Ticker

ALKS (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Dublin 4, Ireland

Fiscal year end

December 31

SEC CIK

1520262

Former names

ANTLER SCIENCE TWO PLC, Antler Science Two Ltd

Frequently asked questions